FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

BACKGROUND: FOLFOX chemotherapy is one of the most commonly used treatments for colorectal cancer (CRC) patients. However, the efficacy and tolerance of FOLFOX therapy varies between patients. The purpose of this study was to explore hub genes associated with primary chemotherapy-resistance and to e...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Genet
Hoofdauteurs: Zhang, Yiyi, Sun, Lijun, Wang, Xiaojie, Sun, Yanwu, Chen, Ying, Xu, Meifang, Chi, Pan, Lu, Xingrong, Xu, Zongbin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020
Onderwerpen:
Genetics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078371/
https://ncbi.nlm.nih.gov/pubmed/32218799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00113
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items